Prescription Drug Diversion and Counterfeiting: Hearings Before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, First-[second] Session, Volume 1
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations
U.S. Government Printing Office, 1986 - Drug control
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
activity Administration adulterated agent Allen American Association believe Bilirakis Board buying called Chairman committee companies concern consumers continuing correct cost counterfeit criminal Customs deal distribution drug diversion effective enforcement expired fact Federal Florida going hearing hospital illegal important indicated institutions invoice involved kind Kowitt license look manufacturers medication merchandise Michigan month nonprofit obtained operation packaging Panama patient period pharmaceutical pharmacists pharmacy physicians pills practice prescription drugs problem profit purchase question received record representatives result retail returned samples scheme sell Service shipped Sikorski Sims sold staff statement stored subcommittee supply tablets talking testimony Thank thing tion United wholesalers Wyden Yeah York
Page 460 - On behalf of the Officers, Executive Committee, and members of the National Association of Retail Druggists, we thank you for the opportunity to appear and continue to participate in the formulation of Medicare Part B outpatient prescription drug coverage . Mr.
Page 164 - ... pricing data; and technical data) which the offeror, including its prospective subcontractor(s), does not want used or disclosed for any purpose other than for evaluation of the proposal. The use and disclosure of any data may be so restricted; provided, that the Government determines that the data is not required to be disclosed under the Freedom of Information Act, 5 USC 552, as amended, and the offeror marks the cover sheet of the proposal with the following legend, specifying the particular...
Page 457 - ... so as a result of the passage of the Act. These institutions, typified by almshouses or pauper hospitals, were supported by subscription and were making their services available to people who could not pay for the services. Today, nonprofits that are engaging in commercial activities with for-profit firms that pay Federal, state, and local taxes for the privilege of doing business, claim the protection of that exemption. That claim flies in the face of the purpose of the exemption and their method...
Page 248 - We will make a copy of your prepared remarks a part of the hearing record, in their entirety.
Page 509 - The committee now stands adjourned. (Whereupon, at 2:58 pm, the subcommittee was adjourned.) (The following material was submitted for the record :) STATEMENT OF SENATOR THOMAS J.
Page 455 - NARD has long been acknowledged as the sole advocate for this vital component of the free enterprise system. NARD members are primarily family businesses.
Page 401 - APhA is the national professional society of pharmacists, representing the third largest health profession that comprises more than 150,000 pharmacy practitioners, pharmaceutical scientists and pharmacy students. Since its founding in 1852, APhA has been a leader in the professional and scientific advancement of pharmacy and in safeguarding the well-being of the individual patient.
Page 12 - ... operation of the diversion market in the United States. As part of their case, the defendants called witnesses who testified that diversion was a standard practice and a time-honored method by which at least some pharmaceutical retailers obtain supplies. As indicated in the previous section, salesmen might sell to diverters to meet quota, to move an oversupply of a certain product, or for various other reasons that were approved or tolerated by the companies. One witness, Robert Brewer, had been...